Antibacterial peptide for maintaining scalp flora health and preparation method and application thereof
By designing and improving the amino acid sequence of antimicrobial peptides and preparing them by solid phase synthesis, the cost and stability of natural antimicrobial peptides in application are solved, and an antimicrobial peptide for scalp care is provided, which significantly inhibits a variety of disease-causing diseases. bacteria improves the maintenance effect of healthy scalp.
Patent Information
- Application Number
- CN202411281077.0
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-12
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2044-09-12
AI Technical Summary
The existing natural antimicrobial peptides are costly, have low activity and poor stability in applications, making them difficult to meet the needs of maintaining the health of scalp flora, and there are few researches on the scalp.
A polypeptide antimicrobial peptide was designed, which was prepared by the improvement and modification of amino acid sequences by solid phase synthesis method, and was used to prepare antimicrobial peptides for scalp care products, with the ability to counter Malassezia furfur, restrict Malassezia, and humans. The significant antibacterial effects of Staphylococcus, Candida albicans and Staphylococcus aureus.
It provides a safe and effective antimicrobial peptide for the treatment of dandruff, seborrheic dermatitis, scalp itching, hair loss and other problems, significantly inhibits target microorganisms, is suitable for scalp care products, and improves the maintenance effect of scalp flora health.
Smart Images

Figure CN118930611A_ABST
Abstract
Description
Technical Field
[0001] The present invention belongs to the technical field of antimicrobial peptides, and in particular relates to an antimicrobial peptide for maintaining the health of scalp flora, and a preparation method and application thereof. Background Art
[0002] The scalp is a unique ecological niche. Its dense hair, numerous sweat glands, sebaceous glands, and high relative humidity create suitable conditions for the colonization and growth of microorganisms. Shedding keratinocytes, mineral ions secreted by sweat glands, and fat secreted by sebaceous glands provide a rich source of nutrition for microorganisms. The microbiome of a normal scalp is mainly composed of bacteria and fungi, with a colonization density of 10 3 -10 5 Every square millimeter, mainly including Staphylococcus, Propionibacterium and Malassezia.
[0003] When the scalp microecological environment is damaged and unbalanced, the scalp microecology is unbalanced, the biodiversity of the scalp microbiome decreases, the flora structure changes, and the host skin function and metabolic activities become abnormal, causing a series of scalp problems and scalp diseases such as dandruff, seborrheic dermatitis, scalp itching, hair loss, etc.
[0004] As a new type of antimicrobial agent, antimicrobial peptides are widely available and have broad-spectrum antimicrobial activity. Compared with traditional antibiotics, most antimicrobial peptides kill bacteria mainly by destroying bacterial cell membranes, which makes it less likely for bacteria to develop drug resistance. They are considered to be good alternatives to antibiotics. Natural antimicrobial peptides have high production costs, low antimicrobial activity, and poor stability, which cannot meet the needs of practical applications. With the continuous in-depth study of the properties, structure, and mechanism of action of existing natural antimicrobial peptides, more and more research is focused on the development of artificial synthetic antimicrobial peptides. Researchers have successfully used various modern biotechnologies to molecularly modify antimicrobial peptides or synthesize new antimicrobial peptides. At present, there are few studies on antimicrobial peptides used to maintain the health of scalp flora. Summary of the invention
[0005] In order to solve the problems in the prior art, the first aspect of the present invention provides an antimicrobial peptide for maintaining the health of scalp flora, wherein the antimicrobial peptide is any one of the following polypeptides (a)-(e):
[0006] (a) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.1, or a polypeptide whose amino acid sequence consists of the amino acid residues shown in SEQ ID NO.1;
[0007] (b) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.2, or a polypeptide whose amino acid sequence consists of the amino acid residues shown in SEQ ID NO.2;
[0008] (c) a polypeptide formed by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence defined in (a) or (b);
[0009] (d) a polypeptide obtained by acetylation of the N-terminus and / or C-terminus of the polypeptide defined in (a) or (b);
[0010] (e) A polypeptide having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence defined in (a) or (b).
[0011] Further preferably, the antimicrobial peptide is any one of P7, P7L, P7K, P7R, P7I, and P7F.
[0012] Preferably, the amino acid sequence of the antimicrobial peptide P7 is shown in SEQ ID NO.1;
[0013] The amino acid sequence of the antimicrobial peptide P7L is shown in SEQ ID NO.3;
[0014] The amino acid sequence of the antimicrobial peptide P7K is shown in SEQ ID NO.4.
[0015] Preferably, the amino acid sequence of the antimicrobial peptide P7R is shown in SEQ ID NO.5;
[0016] The amino acid sequence of the antimicrobial peptide P7I is shown in SEQ ID NO.6;
[0017] The amino acid sequence of the antimicrobial peptide P7F is shown in SEQ ID NO.7.
[0018] Preferably, the antimicrobial peptide is any one of P16, P16L, P16K, P6R, P16I, and P16V.
[0019] Preferably, the amino acid sequence of the antimicrobial peptide P16 is shown in SEQ ID NO.2;
[0020] The amino acid sequence of the antimicrobial peptide P16L is shown in SEQ ID NO.8;
[0021] The amino acid sequence of the antimicrobial peptide P16K is shown in SEQ ID NO.9.
[0022] Preferably, the amino acid sequence of the antimicrobial peptide P16R is shown in SEQ ID NO.10;
[0023] The amino acid sequence of the antimicrobial peptide P16I is shown in SEQ ID NO.11;
[0024] The amino acid sequence of the antimicrobial peptide P16V is shown in SEQ ID NO.12.
[0025] The second aspect of the present invention provides a method for preparing an antimicrobial peptide for maintaining the health of scalp flora, wherein the preparation method is a solid phase synthesis method.
[0026] A third aspect of the present invention provides an application of an antimicrobial peptide for maintaining the health of scalp flora, for preparing a product for preventing or treating scalp diseases.
[0027] Preferably, the skin diseases include dandruff, seborrheic dermatitis, tinea versicolor, and Malassezia folliculitis caused by fungal infection;
[0028] Preferably, the product is any one of a scalp care product, a hair conditioner, a shampoo, and an external medicine.
[0029] The beneficial effects of the present invention are:
[0030] The present invention designs and synthesizes an antimicrobial peptide for maintaining healthy scalp flora, which has good safety and can be used to treat scalp problems such as dandruff, seborrheic dermatitis, scalp itching, and hair loss caused by imbalance of scalp flora; the antimicrobial peptide can be applied to scalp care products, conditioners, shampoos, or topical medicines for driving away dandruff or treating seborrheic dermatitis, scalp itching, and hair loss. The antimicrobial peptide of the present invention has significant antibacterial effects on Malassezia furfur, Malassezia restricta, Staphylococcus hominis, Candida albicans, and Staphylococcus aureus, but has a weaker inhibitory effect on Lactobacillus acidophilus, thereby being more conducive to maintaining healthy scalp flora and having greater application value. BRIEF DESCRIPTION OF THE DRAWINGS
[0031] Figure 1A and Figure 1B The figures are respectively the antibacterial results of different antimicrobial peptides of the present invention added to Malassezia furfur ATCC44344 at a concentration of 10 μg / mL and 20 μg / mL and detected after incubation for 48 h and 72 h;
[0032] Figure 2A and Figure 2B The antibacterial results of different antimicrobial peptides of the present invention in Malassezia restricta are shown in Figures 10 μg / mL and 20 μg / mL, and the results are shown in Figures 72 and 48 hours after incubation.
[0033] Figure 3A and Figure 3BThe antibacterial results of different antimicrobial peptides of the present invention in Staphylococcus hominis are shown in Figures 10 μg / mL and 20 μg / mL, respectively, after incubation for 24 hours and 48 hours;
[0034] Figure 4 The graph is a graph showing the antibacterial results of different antimicrobial peptides of the present invention added to Candida albicans at a concentration of 10 μg / mL and incubated for 24 hours;
[0035] Figure 5 The graph is a graph showing the antibacterial results of different antimicrobial peptides of the present invention added to Staphylococcus aureus at a concentration of 100 μg / mL and incubated for 24 hours;
[0036] Fig. 6A and Figure 6B The graphs show the antibacterial results of different antimicrobial peptides of the present invention added to Lactobacillus acidophilus at a concentration of 10 μg / mL, 20 μg / mL, and 40 μg / mL and detected after incubation for 48 h and 72 h. DETAILED DESCRIPTION
[0037] To make the purpose, technical solution and advantages of the present invention clearer, the technical solution of the present invention will be described in detail below. Obviously, the described embodiments are only part of the embodiments of the present invention, rather than all of the embodiments. Based on the embodiments of the present invention, all other implementation methods obtained by ordinary technicians in this field without creative work belong to the scope of protection of the present invention.
[0038] The first aspect of the present invention provides an antimicrobial peptide for maintaining the health of scalp flora, wherein the antimicrobial peptide is any one of the following polypeptides (a) to (e):
[0039] (a) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.1, or a polypeptide whose amino acid sequence consists of the amino acid residues shown in SEQ ID NO.1;
[0040] (b) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.2, or a polypeptide whose amino acid sequence consists of the amino acid residues shown in SEQ ID NO.2;
[0041] (c) a polypeptide formed by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence defined in (a) or (b);
[0042] (d) a polypeptide obtained by modifying the N-terminus and / or C-terminus of the polypeptide defined in (a) or (b);
[0043] (e) A polypeptide having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence defined in (a) or (b).
[0044] Further preferably, the antimicrobial peptide is any one of P7, P7L, P7K, P7R, P7I, and P7F.
[0045] Preferably, the antimicrobial peptide is P7, and its amino acid sequence is as shown in SEQ ID NO.1.
[0046] The amino acid sequence of the antimicrobial peptide P7L is shown in SEQ ID NO.3;
[0047] The amino acid sequence of the antimicrobial peptide P7K is shown in SEQ ID NO.4.
[0048] The amino acid sequence of the antimicrobial peptide P7R is shown in SEQ ID NO.5;
[0049] The amino acid sequence of the antimicrobial peptide P7I is shown in SEQ ID NO.6;
[0050] The amino acid sequence of the antimicrobial peptide P7F is shown in SEQ ID NO.7.
[0051] Further preferably, the antimicrobial peptide is any one of P16, P16L, P16K, P6R, P16I, and P16V.
[0052] The amino acid sequence of the antimicrobial peptide P16 is shown in SEQ ID NO.2;
[0053] The amino acid sequence of the antimicrobial peptide P16L is shown in SEQ ID NO.8;
[0054] The amino acid sequence of the antimicrobial peptide P16K is shown in SEQ ID NO.9.
[0055] The amino acid sequence of the antimicrobial peptide P16R is shown in SEQ ID NO.10;
[0056] The amino acid sequence of the antimicrobial peptide P16I is shown in SEQ ID NO.11;
[0057] The amino acid sequence of the antimicrobial peptide P16V is shown in SEQ ID NO.12.
[0058] The second aspect of the present invention provides a method for preparing an antimicrobial peptide for maintaining the health of scalp flora, wherein the preparation method is a solid phase synthesis method.
[0059] The third aspect of the present invention provides an application of an antimicrobial peptide for maintaining healthy scalp flora, which is applied to the preparation of a product for preventing or treating scalp diseases caused by an imbalance of scalp microbial flora;
[0060] The product is any one of a scalp care product, a hair conditioner, a shampoo, and an external medicine.
[0061] The above technical solution is described in detail below in conjunction with specific embodiments.
[0062] The experimental methods used in the following examples are conventional methods unless otherwise specified. The materials, reagents, etc. used in the following examples are all commercially available unless otherwise specified.
[0063] Example 1
[0064] This embodiment provides an antimicrobial peptide P7 for maintaining the health of scalp flora, and its amino acid sequence is KRKVRVALKVS, as shown in SEQ ID NO.1.
[0065] This embodiment further provides a method for preparing the antimicrobial peptide, which adopts a solid phase synthesis method, and the specific steps are as follows:
[0066] (1) The order of peptide synthesis is from C-terminus to N-terminus: 20g AM resin is placed in a reaction tube, 15mL / g DCM (dichloromethane) is added, and the mixture is shaken for 45 minutes; the solvent DCM is filtered off through a sand core, and a 3-fold molar excess of Fmoc-Linker-OH (CAS: 145069-56-3) is added, followed by a 6.5-fold molar excess of DIEA (N,N-diisopropylethylamine), and the mixture is shaken for 75 minutes. Seal with methanol; DMF is evaporated off by rotary evaporation, and 20mL / g 20% (V / V) piperidine-DMF solvent is added, washed for 5 minutes, removed, and 20mL / g 20% (V / V) piperidine-DMF solvent is added, and the mixture is washed for 20 minutes. The resin is rinsed twice with DMF (15mL / g), DCM (15mL / g), and DMF (15mL / g), respectively, and shaken for 40 minutes;
[0067] (2) Connect the first amino acid: remove the solvent DCM through a sand core, add 3.5 times molar excess of Fmoc-Ala-OH, add DMF (dimethylformamide) to dissolve, then add 6.5 times molar excess of DIEA (N,N-diisopropylethylamine), shake for 70 minutes, and block with methanol.
[0068] (3) Deprotection: DMF was evaporated off by rotary evaporation, 20 mL / g of 20% (V / V) piperidine-DMF solvent was added, washed for 5 minutes, removed, and 15 mL / g of 20% (V / V) piperidine-DMF solvent was added, and washed for 20 minutes.
[0069] (4) Detection: Draw piperidine solution, take 15 resin pellets, wash three times with ethanol, add detection reagent for detection. Heat at 105-110℃ for 8 minutes. A positive reaction is indicated when the color changes to dark blue.
[0070] (5) Rinse the resin: Rinse the resin twice with DMF (15 mL / g), DCM (15 mL / g), and DMF (15 mL / g) respectively.
[0071] (6) Condensation: Add three times excess of the next amino acid derivative (from C-terminus to nitrogen-terminus) dissolved in DMF, 3.5 times excess of HBTU (benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate) dissolved in DMF into the reaction tube, and then immediately add 16 times molar amount of DIEA and react for 40 minutes.
[0072] (7) Detection: Take 15 resin beads, wash them three times with ethanol, add detection reagent for detection, heat at 105℃-110℃ for 5 minutes, and a colorless reaction indicates a negative reaction.
[0073] (8) Rinse the resin: Rinse the resin twice with DMF (10 mL / g), DCM (10 mL / g), and DMF (10 mL / g) respectively.
[0074] (9) Repeat steps (3) to (8) to connect the amino acids shown in SEQ ID No. 1 from right to left.
[0075] (10) Drain and wash the resin as follows: DMF (15 mL / g) twice, methanol (15 mL / g) twice, DMF (15 mL / g) twice, and DCM (15 mL / g) twice, drain for 10 min.
[0076] (11) Cutting the polypeptide from the resin: The cutting solution used at 25°C contains: 95% (V / V) TFA (trifluoroacetic acid), 1% (V / V) water, 2% (V / V) EDT (mercaptoethanol), and 2% (V / V) TIS (triisopropylsilane); the cutting time is 120 minutes, and the cleavage solution is obtained.
[0077] (12) Blow-drying and washing: The lysate was blown dry with nitrogen, washed with ether six times, and then left to evaporate at room temperature.
[0078] (13) Analysis, purification and freeze drying: The crude polypeptide was purified by high performance liquid chromatography; the polypeptide solution was collected and placed in a freeze dryer for concentration, and freeze-dried to obtain a white powder, thereby obtaining an antimicrobial peptide with the structure of KRKVRVALKVS.
[0079] The detection reagent is ninhydrin.
[0080] Example 2
[0081] This embodiment provides an antimicrobial peptide P16 for maintaining the health of scalp flora, and its amino acid sequence is KWLKRIKKLFAN, as shown in SEQ ID NO.2.
[0082] This embodiment further provides a method for preparing the antimicrobial peptide, which adopts a solid phase synthesis method, and the specific steps are as follows:
[0083] (1) The order of peptide synthesis is from C-terminus to N-terminus: 20g AM resin is placed in a reaction tube, 15mL / g DCM (dichloromethane) is added, and the mixture is shaken for 45 minutes; the solvent DCM is filtered off through a sand core, and a 3-fold molar excess of Fmoc-Linker-OH (CAS: 145069-56-3) is added, followed by a 6.5-fold molar excess of DIEA (N,N-diisopropylethylamine), and the mixture is shaken for 75 minutes. Seal with methanol; DMF is evaporated off by rotary evaporation, and 20mL / g 20% (V / V) piperidine-DMF solvent is added, washed for 5 minutes, removed, and 20mL / g 20% (V / V) piperidine-DMF solvent is added, and the mixture is washed for 20 minutes. The resin is rinsed twice with DMF (15mL / g), DCM (15mL / g), and DMF (15mL / g), respectively, and shaken for 40 minutes;
[0084] (2) Connect the first amino acid: remove the solvent DCM through a sand core, add 3.5 times molar excess of Fmoc-Ala-OH, add DMF (dimethylformamide) to dissolve, then add 6.5 times molar excess of DIEA (N,N-diisopropylethylamine), shake for 70 minutes, and block with methanol.
[0085] (3) Deprotection: DMF was evaporated off by rotary evaporation, 20 mL / g of 20% (V / V) piperidine-DMF solvent was added, washed for 5 minutes, removed, and 15 mL / g of 20% (V / V) piperidine-DMF solvent was added, and washed for 20 minutes.
[0086] (4) Detection: Draw piperidine solution, take 15 resin pellets, wash three times with ethanol, add detection reagent for detection. Heat at 105-110℃ for 8 minutes. A positive reaction is indicated when the color changes to dark blue.
[0087] (5) Rinse the resin: Rinse the resin twice with DMF (15 mL / g), DCM (15 mL / g), and DMF (15 mL / g) respectively.
[0088] (6) Condensation: Add three times excess of the next amino acid derivative (from C-terminus to nitrogen-terminus) dissolved in DMF, 3.5 times excess of HBTU (benzotriazole-N,N,N',N'-tetramethyluronium hexafluorophosphate) dissolved in DMF into the reaction tube, and then immediately add 16 times molar amount of DIEA and react for 40 minutes.
[0089] (7) Detection: Take 15 resin beads, wash them three times with ethanol, add detection reagent for detection, heat at 105℃-110℃ for 5 minutes, and a colorless reaction indicates a negative reaction.
[0090] (8) Rinse the resin: Rinse the resin twice with DMF (10 mL / g), DCM (10 mL / g), and DMF (10 mL / g) respectively.
[0091] (9) Repeat steps (3) to (8) to connect the amino acids shown in SEQ ID No. 2 from right to left.
[0092] (10) Drain and wash the resin as follows: DMF (15 mL / g) twice, methanol (15 mL / g) twice, DMF (15 mL / g) twice, and DCM (15 mL / g) twice, drain for 10 min.
[0093] (11) Cutting the polypeptide from the resin: The cutting solution used at 25°C contains: 95% (V / V) TFA (trifluoroacetic acid), 1% (V / V) water, 2% (V / V) EDT (mercaptoethanol), and 2% (V / V) TIS (triisopropylsilane); the cutting time is 120 minutes, and the cleavage solution is obtained.
[0094] (12) Blow-drying and washing: The lysate was blown dry with nitrogen, washed with ether six times, and then left to evaporate at room temperature.
[0095] (13) Analysis, purification and freeze drying: The crude polypeptide was purified by high performance liquid chromatography; the polypeptide solution was collected and placed in a freeze dryer for concentration, and freeze-dried to obtain a white powder, thereby obtaining an antimicrobial peptide with the structure of KWLKRIKKLFAN.
[0096] The detection reagent is ninhydrin.
[0097] Example 3
[0098] This embodiment provides an antimicrobial peptide P7L for maintaining the health of scalp flora, which is different from Embodiment 1 only in that its amino acid sequence is KRKVRVLLKVS, as shown in SEQ ID NO.3.
[0099] Example 4
[0100] This embodiment provides an antimicrobial peptide P7K for maintaining the health of scalp flora, which is different from Example 1 only in that its amino acid sequence is KRKVRVKLKVS, as shown in SEQ ID NO.4.
[0101] Example 5
[0102] This embodiment provides an antimicrobial peptide P7R for maintaining the health of scalp flora, which is different from Embodiment 1 only in that its amino acid sequence is KRKVRVRLKVS, as shown in SEQ ID NO.5.
[0103] Example 6
[0104] This embodiment provides an antimicrobial peptide P7I for maintaining the health of scalp flora, which is different from Embodiment 1 only in that its amino acid sequence is KRKVRVILKVS, as shown in SEQ ID NO.6.
[0105] Example 7
[0106] This embodiment provides an antimicrobial peptide P7F for maintaining the health of scalp flora, which is different from Embodiment 1 only in that its amino acid sequence is KRKVRVFLKVS, as shown in SEQ ID NO.7.
[0107] Example 8
[0108] This embodiment provides an antimicrobial peptide P16L for maintaining the health of scalp flora, which is different from Example 1 only in that its amino acid sequence is KWLKRIKKLFLN, as shown in SEQ ID NO.8.
[0109] Example 9
[0110] This embodiment provides an antimicrobial peptide P16K for maintaining the health of scalp flora, which is different from Example 1 only in that its amino acid sequence is KWLKRIKKLFKN, as shown in SEQ ID NO.9.
[0111] Example 10
[0112] This embodiment provides an antimicrobial peptide P16R for maintaining the health of scalp flora, which is different from Example 1 only in that its amino acid sequence is KWLKRIKKLFRN, as shown in SEQ ID NO.10.
[0113] Embodiment 11
[0114] This embodiment provides an antimicrobial peptide P16I for maintaining the health of scalp flora, which is different from Embodiment 1 only in that its amino acid sequence is KWLKRIKKLFIN, as shown in SEQ ID NO.11.
[0115] Example 12
[0116] This embodiment provides an antimicrobial peptide P16V for maintaining the health of scalp flora, which is different from Example 1 only in that its amino acid sequence is KWLKRIKKLFVN, as shown in SEQ ID NO.12.
[0117] Experimental example
[0118] 1. Antibacterial experiment:
[0119] In the liquid culture medium antibacterial experiment of detecting the antimicrobial peptides described in Examples 1-12, the detected bacteria were Malassezia furfur ATCC 44344, Malassezia restricta ATCC33081, Staphylococcus hominis (ATCC 23976), Candida albicans ATCC 14053, Staphylococcus aureus ATCC 25913, Lactobacillus acidophilus ATCC 4356, CAP was chloramphenicol, KCZ was ketoconazole, as the control group, all of which were commercially available.
[0120] 2. Experimental results
[0121] The results of the antibacterial test on Malassezia furfur are as follows Figure 1A and Figure 1B As shown, after adding 10 μg / mL antimicrobial peptides and incubating for 48 hours and 72 hours, the inhibition rate of all antimicrobial peptides on Malassezia furfur reached 100%. Similarly, after adding 20 μg / mL antimicrobial peptides and incubating for 48 hours and 72 hours, the inhibition rate of all antimicrobial peptides on Malassezia furfur reached 100%.
[0122] The results of inhibition of Malassezia restriction Figure 2A and Figure 2BAs shown, after adding 10 μg / mL antimicrobial peptides and incubating for 48 hours, the inhibition rate of antimicrobial peptides P7L, P7K, P7R, P7I, P7F, P16L, and P16R against Malassezia restricta reached 100%; after continuous incubation for 72 hours, the inhibition rate of P7K, P7R, P7F, P16L, and P16R against Malassezia restricta remained unchanged at 100%. Similarly, after adding 20 μg / mL antimicrobial peptides and incubating for 48 hours, the inhibition rate of antimicrobial peptides P7, P16, P7L, P7K, P7R, P7I, P16L, P16K, P16R, P16I, and P16V against Malassezia restricta reached 100%; after continuous incubation for 72 hours, the inhibition rate of antimicrobial peptides P7, P7L, P7K, P7R, P7I, P16L, P6K, and P16R against Malassezia restricta remained at 100%.
[0123] The results of inhibition of human Staphylococcus aureus are as follows Figure 3A and Figure 3B As shown, after adding 10 μg / mL and 20 μg / mL antimicrobial peptides and incubating for 24 hours, the inhibition rate of all antimicrobial peptides on human Staphylococcus aureus reached 100%. After continuous incubation for 48 hours, the inhibition rate of all antimicrobial peptides on human Staphylococcus aureus reached 100%.
[0124] The results of inhibition of Candida albicans are as follows Figure 4 As shown, after adding 10 μg / mL antimicrobial peptides and incubating for 24 hours, the inhibition rate of antimicrobial peptides P16, P7K, P7R, P7I, P16L, P16K, P16R, P16I, and P16V against Candida albicans reached 100%.
[0125] The antibacterial results against Staphylococcus aureus are as follows Figure 5 As shown, after adding 100 μg / mL antimicrobial peptides and incubating for 24 hours, the inhibition rate of antimicrobial peptides P7K, P7R, P7I, P16L, P16R, and P16I against Staphylococcus aureus reached 100%.
[0126] The results of inhibition of Lactobacillus acidophilus are as follows Fig. 6A and 6B As shown: after adding 10μg / mL, 20μg / mL, and 40μg / mL antimicrobial peptides and incubating for 48 hours and 72 hours, the inhibition rate of all antimicrobial peptides on Lactobacillus acidophilus was less than 30%.
[0127] The present invention designs and synthesizes an antimicrobial peptide for maintaining healthy scalp flora, which has good safety and can be used to treat scalp problems such as dandruff, seborrheic dermatitis, scalp itching, and hair loss caused by imbalance of scalp flora; the antimicrobial peptide can be applied to scalp care products, conditioners, shampoos, or topical medicines for driving away dandruff or treating seborrheic dermatitis, scalp itching, and hair loss. The antimicrobial peptide of the present invention has significant antibacterial effects on Malassezia furfur, Malassezia restricta, Staphylococcus hominis, Candida albicans, and Staphylococcus aureus, but has a weaker inhibitory effect on Lactobacillus acidophilus, thereby being more conducive to maintaining healthy scalp flora and having greater application value.
[0128] The above is only a specific embodiment of the present invention, but the protection scope of the present invention is not limited thereto. Any person skilled in the art can easily think of changes or substitutions within the technical scope disclosed by the present invention, which should be included in the protection scope of the present invention. Therefore, the protection scope of the present invention should be based on the protection scope of the claims.
Claims
1. An antimicrobial peptide for maintaining healthy scalp flora, characterized in that: The antimicrobial peptide is any one of the following polypeptides (a)-(e): (a) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.1, or a polypeptide whose amino acid sequence consists of the amino acid residues shown in SEQ ID NO.1; (b) a polypeptide whose amino acid sequence includes the amino acid sequence shown in SEQ ID NO.2, or a polypeptide whose amino acid sequence consists of the amino acid residues shown in SEQ ID NO.2; (c) a polypeptide formed by substituting and / or deleting and / or adding one or more amino acid residues of the amino acid sequence defined in (a) or (b); (d) a polypeptide obtained by modifying the N-terminus and / or C-terminus of the polypeptide defined in (a) or (b); (e) A polypeptide having 99% or more, 95% or more, 90% or more, 85% or more, or 80% or more homology with the amino acid sequence defined in (a) or (b).
2. The antimicrobial peptide for maintaining healthy scalp flora according to claim 1, characterized in that: The antimicrobial peptide is any one of P7, P7L, P7K, P7R, P7I, and P7F.
3. The antimicrobial peptide for maintaining healthy scalp flora according to claim 2, characterized in that: The amino acid sequence of the antimicrobial peptide P7 is shown in SEQ ID NO.1; The amino acid sequence of the antimicrobial peptide P7L is shown in SEQ ID NO.3; The amino acid sequence of the antimicrobial peptide P7K is shown in SEQ ID NO.
4.
4. The antimicrobial peptide for maintaining healthy scalp flora according to claim 2, characterized in that: The amino acid sequence of the antimicrobial peptide P7R is shown in SEQ ID NO.5; The amino acid sequence of the antimicrobial peptide P7I is shown in SEQ ID NO.6; The amino acid sequence of the antimicrobial peptide P7F is shown in SEQ ID NO.
7.
5. The antimicrobial peptide for maintaining healthy scalp flora according to claim 1, characterized in that: The antimicrobial peptide is any one of P16, P16L, P16K, P6R, P16I, and P16V.
6. The antimicrobial peptide for maintaining healthy scalp flora according to claim 5, characterized in that: The amino acid sequence of the antimicrobial peptide P16 is shown in SEQ ID NO.2; The amino acid sequence of the antimicrobial peptide P16L is shown in SEQ ID NO.8; The amino acid sequence of the antimicrobial peptide P16K is shown in SEQ ID NO.
9.
7. The antimicrobial peptide for maintaining healthy scalp flora according to claim 5, characterized in that: The amino acid sequence of the antimicrobial peptide P16R is shown in SEQ ID NO.10; The amino acid sequence of the antimicrobial peptide P16I is shown in SEQ ID NO.11; The amino acid sequence of the antimicrobial peptide P16V is shown in SEQ ID NO.
12.
8. A method for preparing an antimicrobial peptide for maintaining healthy scalp flora according to any one of claims 1 to 7, characterized in that: The preparation method is a solid phase synthesis method.
9. Use of the antimicrobial peptide according to any one of claims 1 to 7 in the preparation of a product for preventing or treating scalp diseases caused by an imbalance of scalp microbial flora.
10. The use according to claim 9, characterized in that: The product is any one of a scalp care product, a hair conditioner, a shampoo, and an external medicine.
Citation Information
Patent Citations
Antibacterial peptide and application thereof
CN115974975A
Antibacterial peptides
CN118201949A
Antimicrobial peptides, compositions comprising the same and uses thereof
US20150344527A1
